Abstract
Talazoparib, a poly(ADP-ribose) polymerase inhibitor, has demonstrated efficacy in the treatment of advanced breast and prostate cancers in Western po......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
